SKYLER MARTIN: Open Payments
NPI 1093195091 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,295 in 111 payments from 34 companies in 2025. Trend: 2023 $1,990 · 2024 $2,532 · 2025 $2,295
Food & beverage: $2,295
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $201 |
| Novartis Pharmaceuticals Corporation | 9 | $175 |
| Janssen Biotech, Inc. | 9 | $166 |
| Genentech USA, Inc. | 8 | $160 |
| Celgene Corporation | 6 | $144 |
| Merck Sharp & Dohme LLC | 6 | $144 |
| AstraZeneca Pharmaceuticals LP | 8 | $143 |
| BeOne Medicines USA, Inc. | 5 | $102 |
| PFIZER INC. | 6 | $99 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
Products named: KEYTRUDA, Enhertu, OPDIVO, DATROWAY, PLUVICTO, REBLOZYL, Polivy, BRUKINSA.
Industry payments across AL — which companies pay providers there.
